Your browser doesn't support javascript.
loading
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.
van Barele, Mark; Rieborn, Amy; Heemskerk-Gerritsen, Bernadette A M; Obdeijn, Inge-Marie; Koppert, Linetta B; Loo, Claudette E; Tollenaar, Rob A E M; Ausems, Margreet G E M; van de Beek, Irma; Berger, Lieke P V; de Boer, Maaike; van Hest, Liselot P; Kets, C Marleen; Rookus, Matti; Schmidt, Marjanka K; Jager, Agnes; Hooning, Maartje J.
Afiliação
  • van Barele M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • Rieborn A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • Obdeijn IM; Department of Radiology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • Koppert LB; Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • Loo CE; Department of Radiology, Division of Diagnostic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Tollenaar RAEM; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
  • Ausems MGEM; Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • van de Beek I; Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Berger LPV; Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • de Boer M; Division of Medical Oncology | Department of Internal Medicine, GROW-School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • van Hest LP; Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
  • Kets CM; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Rookus M; Department of Epidemiology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands. m.hooning@erasmusmc.nl.
Breast Cancer Res Treat ; 194(1): 159-170, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35507134
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda